These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 35935941)
1. Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer. Wang S; Fu Y; Kuerban K; Liu J; Huang X; Pan D; Chen H; Zhu Y; Ye L Front Immunol; 2022; 13():933165. PubMed ID: 35935941 [TBL] [Abstract][Full Text] [Related]
2. Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma. Hur H; Ham IH; Lee D; Jin H; Aguilera KY; Oh HJ; Han SU; Kwon JE; Kim YB; Ding K; Brekken RA BMC Cancer; 2017 Jan; 17(1):87. PubMed ID: 28143619 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Discoidin Domain Receptor 1 Prevents Stroma-Induced Peritoneal Metastasis in Gastric Carcinoma. Jin H; Ham IH; Oh HJ; Bae CA; Lee D; Kim YB; Son SY; Chwae YJ; Han SU; Brekken RA; Hur H Mol Cancer Res; 2018 Oct; 16(10):1590-1600. PubMed ID: 29866925 [TBL] [Abstract][Full Text] [Related]
4. DDR1 is a Novel Biomarker and Potential Therapeutic Target for the Combination Treatment of Liver Hepatocellular Carcinoma. Li T; Hu H; Song Y; Shi Y; Hu D; Shen W; Ning B Cancer Control; 2024; 31():10732748241286257. PubMed ID: 39284684 [TBL] [Abstract][Full Text] [Related]
5. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition. Xie R; Wang X; Qi G; Wu Z; Wei R; Li P; Zhang D Tumour Biol; 2016 Sep; 37(9):12049-12059. PubMed ID: 27179963 [TBL] [Abstract][Full Text] [Related]
6. DDR1 promotes migration and invasion of breast cancer by modulating the Src-FAK signaling. Han Q; Xiao F; Ma L; Zhou J; Wang L; Cheng H; Zhu J; Yao F; Lyu J; Du L Neoplasma; 2022 Sep; 69(5):1154-1164. PubMed ID: 35818965 [TBL] [Abstract][Full Text] [Related]
7. Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice. Sun X; Gupta K; Wu B; Zhang D; Yuan B; Zhang X; Chiang HC; Zhang C; Curiel TJ; Bendeck MP; Hursting S; Hu Y; Li R J Biol Chem; 2018 Feb; 293(8):2841-2849. PubMed ID: 29298894 [TBL] [Abstract][Full Text] [Related]
8. DDR1 Drives Malignant Progression of Gastric Cancer by Suppressing HIF-1α Ubiquitination and Degradation. Wei Z; Li J; Zhong L; Yang D; Li W; Chen W; Zhou H; He Y; Song W; Wang B; Zeng L Adv Sci (Weinh); 2024 Sep; 11(35):e2308395. PubMed ID: 39024501 [TBL] [Abstract][Full Text] [Related]
9. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Sun X; Wu B; Chiang HC; Deng H; Zhang X; Xiong W; Liu J; Rozeboom AM; Harris BT; Blommaert E; Gomez A; Garcia RE; Zhou Y; Mitra P; Prevost M; Zhang D; Banik D; Isaacs C; Berry D; Lai C; Chaldekas K; Latham PS; Brantner CA; Popratiloff A; Jin VX; Zhang N; Hu Y; Pujana MA; Curiel TJ; An Z; Li R Nature; 2021 Nov; 599(7886):673-678. PubMed ID: 34732895 [TBL] [Abstract][Full Text] [Related]
10. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells. Vella V; Malaguarnera R; Nicolosi ML; Palladino C; Spoleti C; Massimino M; Vigneri P; Purrello M; Ragusa M; Morrione A; Belfiore A Oncotarget; 2017 Jun; 8(26):43248-43270. PubMed ID: 28591735 [TBL] [Abstract][Full Text] [Related]
11. Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway. Pan Y; Han M; Zhang X; He Y; Yuan C; Xiong Y; Li X; Zeng C; Lu K; Zhu H; Lu X; Liu Q; Liang H; Liao Z; Ding Z; Zhang Z; Chen X; Zhang W; Zhang B Cell Oncol (Dordr); 2022 Feb; 45(1):163-178. PubMed ID: 35089546 [TBL] [Abstract][Full Text] [Related]
12. Discoidin domain receptors: A promising target in melanoma. Reger de Moura C; Battistella M; Sohail A; Caudron A; Feugeas JP; Podgorniak MP; Pages C; Mazouz Dorval S; Marco O; Menashi S; Fridman R; Lebbé C; Mourah S; Jouenne F Pigment Cell Melanoma Res; 2019 Sep; 32(5):697-707. PubMed ID: 31271515 [TBL] [Abstract][Full Text] [Related]
13. DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor-infiltrating T cells through IL-18. Duan X; Xu X; Zhang Y; Gao Y; Zhou J; Li J Cancer Sci; 2022 Nov; 113(11):3672-3685. PubMed ID: 35969377 [TBL] [Abstract][Full Text] [Related]
14. A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer. Liu J; Chiang HC; Xiong W; Laurent V; Griffiths SC; Dülfer J; Deng H; Sun X; Yin YW; Li W; Audoly LP; An Z; Schürpf T; Li R; Zhang N J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37328286 [TBL] [Abstract][Full Text] [Related]
15. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells. Song J; Chen X; Bai J; Liu Q; Li H; Xie J; Jing H; Zheng J Tumour Biol; 2016 Aug; 37(8):11509-21. PubMed ID: 27020590 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma. Nokin MJ; Darbo E; Travert C; Drogat B; Lacouture A; San José S; Cabrera N; Turcq B; Prouzet-Mauleon V; Falcone M; Villanueva A; Wang H; Herfs M; Mosteiro M; Jänne PA; Pujol JL; Maraver A; Barbacid M; Nadal E; Santamaría D; Ambrogio C JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759499 [TBL] [Abstract][Full Text] [Related]
18. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition. Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676 [TBL] [Abstract][Full Text] [Related]
19. DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6. Zhang X; Hu Y; Pan Y; Xiong Y; Zhang Y; Han M; Dong K; Song J; Liang H; Ding Z; Zhang X; Zhu H; Liu Q; Lu X; Feng Y; Chen X; Zhang Z; Zhang B Oncogene; 2022 Mar; 41(12):1821-1834. PubMed ID: 35140331 [TBL] [Abstract][Full Text] [Related]
20. Signaling by discoidin domain receptor 1 in cancer metastasis. Gadiya M; Chakraborty G Cell Adh Migr; 2018; 12(4):315-323. PubMed ID: 30187813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]